Thu, Jun 08
|Virtual Event via Zoom
FDA Oncology Center of Excellence Presents
FDA Listening Session "Drug Development in Molecular Subsets of Non-Small Cell Lung Cancer – Challenges and Opportunities from a Patient Perspective”
Time & Location
Jun 08, 2023, 2:30 PM – 4:00 PM
Virtual Event via Zoom
About the Event
Register now to join FDA and the representatives from the following patient advocacy groups:
ALK Fusion; ALK Positive, BRAF Bombers, EGFR Resisters, Exon 20 Group at ICAN, KRAS Kickers, MET Crusaders, NTRKers, RET Renegades and the ROS1ders
Discussion topics includes:
- Targeted Therapy Clinical Trials
- Survivorship and Quality of Life
- Biomarker Testing
Date: June 8, 2023, 2:30-4:00 pm, ET
Coordinators: Drs. Luckson Mathieu, Satinder (Mona) Choudhary, and Harpreet Singh
After registering, you will receive a confirmation email containing the link and information to join the webinar on June 8th.
Register:
https://fda.zoomgov.com/webinar/register/WN_I7xkiO9cRKKl1MA7AwHjUA
This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.
© 2024 KRAS Cancer Connect. All rights reserved. Nonprofit EIN 85-4372947